Skip to main content

Peer Review reports

From: Reduced mortality and morbidity associated with metformin and SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus and cirrhosis

Original Submission
31 Jul 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
18 Sep 2023 Reviewed Reviewer Report
25 Sep 2023 Reviewed Reviewer Report
10 Nov 2023 Author responded Author comments - Daniel Jamorabo
Resubmission - Version 4
10 Nov 2023 Submitted Manuscript version 4
20 Nov 2023 Author responded Author comments - Daniel Jamorabo
Resubmission - Version 5
20 Nov 2023 Submitted Manuscript version 5
21 Nov 2023 Author responded Author comments - Daniel Jamorabo
Resubmission - Version 6
21 Nov 2023 Submitted Manuscript version 6
21 Nov 2023 Author responded Author comments - Daniel Jamorabo
Resubmission - Version 7
21 Nov 2023 Submitted Manuscript version 7
4 Dec 2023 Reviewed Reviewer Report
8 Dec 2023 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
8 Dec 2023 Editorially accepted
19 Dec 2023 Article published 10.1186/s12876-023-03085-8

You can find further information about peer review here.

Back to article page